Avience Biomedicals lists on NSE SME after 385.32x, ₹30.24cr IPO
Business
Avience Biomedicals, a medical device company, is officially joining the NSE SME platform Thursday.
Their IPO was a huge hit, oversubscribed by 385.32 times, raising ₹30.24 crore through fresh shares at ₹208 each.
Non-institutional 597.23x, Uttar Pradesh facility plans
Non-institutional investors led the charge, subscribing 597.23 times, while retail investors followed with 401.36 times.
To get in, retail applicants needed ₹2.5 lakh for the minimum lot.
The funds will help Avience build a new facility in Uttar Pradesh and boost working capital.
With FY25 income of ₹45.97 crore and net profit of ₹7.23 crore, they're starting strong on their listing day.